The executive committee of Johnson & Johnson is the principal management group responsible for the strategic operations and allocation of the resources of the company, overseeing and coordinating the activities of the consumer, pharmaceutical, and medical devices business segments. The company competes with companies both locally and globally, with competition in research, involving the development and improvement of new and existing products and processes, being particularly significant. The competitive environment requires substantial investments in continuing research, and the company is committed to creating value by developing accessible, high-quality, innovative products and services. In 2017, $10.6 billion was invested in research and development and $35.2 billion spent on acquisitions, reflecting management's commitment to create life-enhancing innovations and to create value through partnerships. A critical driver of the company's success is the 134,000 diverse employees that work across more than 260 operating companies, which are located in more than 60 countries. Employees are empowered and inspired to lead with the company's credo and purpose as guides, allowing every employee to use the company's reach and size to advance the company's purpose and to also lead with agility and urgency. Leveraging extensive resources across the enterprise enables the company to innovate and execute with excellence, ensuring a focus on addressing the unmet needs of society and investing for an enduring impact. The company’s operational flexibility is enhanced through strategic resource allocation, allowing for effective management of investments and operational efficiencies. The company’s commitment to research and development is evident in its significant expenditures, which are aimed at delivering high-quality and innovative products. The company remains focused on addressing the unmet needs of society every day and investing for an enduring impact, ultimately delivering value to its patients, consumers, healthcare professionals, employees, communities, and shareholders. The company’s ability to mobilize and deploy IT-based resources, combined with leveraging the value of other resources and capabilities, underscores the importance of IT capability in transforming the firm into a competitive force. The development and maintenance of customer demand for the company's consumer products involve significant expenditures for advertising and promotion, which are critical to sustaining competitive advantage in a rapidly evolving market. The company is committed to creating value through partnerships that will profoundly change the trajectory of health for humanity, reflecting a strategic alignment of business objectives with operational capabilities. The company’s investments in technology and innovation are designed to enhance its competitive positioning and improve market responsiveness, ensuring that it remains agile in the face of changing market dynamics. The integration of technology capabilities into business processes is essential for optimizing performance and achieving strategic goals, thereby enhancing overall organizational effectiveness and resilience in a competitive landscape.